Teladoc Health, Inc. (LON:0LDR)
London · Delayed Price · Currency is GBP · Price in USD 7.65
-0.15 (-1.93%)
At close: Sep 12, 2025
Teladoc Health Market Cap
Teladoc Health has a market cap or net worth of 1.02 billion as of September 17, 2025. Its market cap has increased by 14.69% in one year.
Market Cap
1.02B
Enterprise Value
1.28B
Revenue
1.86B
Ranking
n/a
PE Ratio
n/a
Stock Price
7.65
Market Cap Chart
Since July 1, 2015, Teladoc Health's market cap has increased from 675.25M to 1.02B, an increase of 50.90%. That is a compound annual growth rate of 4.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 15, 2025 | 996.52M | -20.28% |
| Dec 31, 2024 | 1.25B | -55.37% |
| Dec 29, 2023 | 2.80B | -11.87% |
| Dec 30, 2022 | 3.18B | -70.72% |
| Dec 31, 2021 | 10.86B | -48.87% |
| Dec 31, 2020 | 21.23B | 364.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 60.53B |
| Haleon | 32.39B |
| Smith & Nephew | 12.20B |
| ConvaTec Group | 4.78B |
| Hikma Pharmaceuticals | 3.61B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.72B |